Records containing: Ulcerative Colitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-04-02A Randomized, Placebo-controlled Clinical Trial Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Subsequent Dietary Fiber in Patients With Moderate Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2024-03-26Bowel Urgency in Inflammatory Bowel Disease
-
CLINICAL_TRIALS study record update · 2024-03-26Postoperative and Functional Outcomes of Transanal Tran-section and Single-Stapled (TTSS) Ileal Pouch-Anal Anastomosis in Ulcerative Colitis Patients
-
CLINICAL_TRIALS study record update · 2024-03-25Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2024-03-21ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-03-20The Canadian Children Inflammatory Bowel Disease Network (CIDsCaNN): A Partnership With the CH.I.L.D. Foundation: Multi-center Inception Cohort Study
-
CLINICAL_TRIALS study record update · 2024-03-15High Dimensional Mass Cytometry as a Tool to Understand Ozanimod's Mechanism of Action (MOA)
-
CLINICAL_TRIALS study record update · 2024-03-15Multicenter Study Evaluating the Persistence, Efficacy and Tolerability of Methotrexate in Inflammatory Bowel Disease Patients
-
CLINICAL_TRIALS study record update · 2024-03-12Investigating the Safety, Feasibility, and Optimal Dose of Fluorescently Labeled Adalimumab-680LT for Visualizing Drug Targeting in Inflammatory Bowel Diseases
-
CLINICAL_TRIALS study record update · 2024-03-12Controlling the Mental Health for a Better Response to Treatment in Patients With Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2024-03-06Efficacy of Energy Therapy in the Management of Chronic Pain and Associated Medical Condition in Children and Adolescents.
-
CLINICAL_TRIALS study record update · 2024-03-05A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-finding Study to Evaluate the Efficacy and Safety of IMU-838 for Induction and Maintenance Therapy in Moderate-to-severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2024-03-01A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Clinical Study on the Effecacy and Safety of Different Dosing Regimens of Hemay007 in Patients With Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2024-02-28Exploring Patient and Healthcare Professional Views and Experiences of the Current and Recommended Monitoring Strategies for Inflammatory Conditions Treated With Commonly Used Immune Suppressing Drugs
-
CLINICAL_TRIALS study record update · 2024-02-28A Phase Ib Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Preliminary Efficacy of Single and Multiple Administration of AK101 in Subjects With Moderately to Severely Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2024-02-28First-line Treatment With Infliximab Versus Corticosteroids in Children With Newly Diagnosed Moderate to Severe Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2024-02-26REFOCUS: Refined Fecal Microbiota Transplantation (FMT) Delivered by Oral Capsules for Induction of Remission in Mild to Moderate Ulcerative Colitis - a Phase I Study
-
CLINICAL_TRIALS study record update · 2024-02-26Phase Ib Escalating Dose, Open-Label, Signal-Finding Study to Evaluate the Safety, Tolerability, and Short-Term Efficacy of the Anti-Light Monoclonal Antibody MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis Who Previously Failed Treatment With an Anti-TNFα Agent
-
CLINICAL_TRIALS study record update · 2024-02-23A Norwegian Study of Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication Within Rheumatology and Gastroenterology: the Nor-vaC Study
-
CLINICAL_TRIALS study record update · 2024-02-20Efficacy of a Lacto-ovo Vegetarian Diet in Mild to Moderate IBD
-
CLINICAL_TRIALS study record update · 2024-02-20Assessment of Patient-reported Symptoms and Endoscopic, Histologic, and Biomarker Outcomes in Patients With Acute Pouchitis Treated With Antibiotics
-
CLINICAL_TRIALS study record update · 2024-02-15A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase Ib Study to Investigate the Safety, Tolerability, Pharmacokinetics, Preliminary Efficacy, and Pharmacodynamics of Subcutaneously Administered RO7049665 in Participants With Active Ulcerative Colitis
-
CLINICAL_TRIALS study record update · 2024-02-14Non-invasive Monitoring of Disease Activity in Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography
-
CLINICAL_TRIALS study record update · 2024-02-08A Multicenter, Randomized, Placebo-Controlled, Multiple-Ascending-Dose Investigation of the Oral Anti-Inflammatory Agent BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
-
CLINICAL_TRIALS study record update · 2024-02-07IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS OF NATURAL HISTORY AND RESPONSE TO BIOTHERAPIES IN INFLAMMATORY BOWEL DISEASE : i-BANK